MULTIPLEX HYBRIDIZATION SYSTEM FOR IDENTIFICATION OF PATHOGENIC <i>MYCOBACTERIUM</i> AND METHOD OF USE

Abstract: A method for species-specific identification of a Mycobacterium species is provided. Also disclosed is a method for identifying the species of Mycobacterium present in a sample. A device is disclosed for the detection of Mycobacterium . Mycobacterium -specific oligonucleotides are also disclosed, as are kits.

Description: MULTIPLEX HYBRIDIZATION SYSTEM FOR IDENTIFICATION OF PATHOGENIC MYCOBACTERIUM AND METHOD OF USE FIELD This disclosure relates to a method of detecting mycobacteπal infection m a subject In one embodiment, the method allows the identification of the Mycobacterium species involved in the infection BACKGROUND The genus Mycobacterium is responsible for more disease world-wide than all other bacterial genera combined Mycobacteπa are small, 0 5 1 μm, weakly gram positive bacilli that have two characteristic bacteπologic features First, the cell walls of these organisms contain very long chain fatty acid esters known as myco c acids (lipids typically having chain lengths of 70 to 90 carbons) This unusual cell envelope allows the mycobacteπa to be impervious to many antiseptic solutions and antibiotics Secondly, the pathogenic mycobacteπa have an unusually slow growth rate Unlike typical bacterial pathogens such as E colt or Staphylococcus aureus, which double in 20-30 minutes and grow to high densities overnight m culture media, M avium and M tuberculosis double approximately every 24 hours Thus it can take three to four weeks to obtain a dense liquid culture or a visible colony of mycobacteπa on a plate The best known property of the genus is the ability of the bacteria to resist decolorization by weak acids after staining, hence the term "acid fast bacilli" (Wayne "Cultivation of Mycobacterium tuberculosis for research purposes" , in Tuberculosis Pathogenesis, Protection, and Control, ASM Press, Bloom BR (ed), Washington, DC, 1994, pp 73-84) Withm the genus Mycobactena, there are a number of closely related species that have been grouped into complexes Currently, over 60 species of mycobactena have been well defined Species other than M tuberculosis and M leprae have been termed the "environmental mycobactena, " many of which are known pathogens For example, M kansasu is an important pulmonary pathogen, along with the M avium complex The Mycobacterium avium complex (MAC) mcludes two species, M avium and M intracellulare Though M avium was originally identified as a pathogen of birds, it is now known that both M avium and M intracellulare are environmental saprophytes that survive well in soil, water, and food, and can be carried by animals (Inderhed et al , Clin Mtcrobiol Rev 6 266 310, 1993, Shinnick and Good, Eur J Clin Mtcrobiol Infect Dis 13 884-901 , 1994) MAC is an opportunistic, rather than innate pathogen m humans, it causes disease primarily m immuno-compromised patients MAC causes three classical disease syndromes disseminated MAC, pulmonary MAC and MAC cervical lymphadenitis, the most common of which is disseminated MAC (Horsburgh "Epidemiology of Mycobacterium avium complex," in Mycobacterium avium Complex Infection Progress m Research and Treatment, Marcel Dekker, Inc , Korvick and Benson (eds), New York, 1996, pp 1-22 The Mycobacterium tuberculosis complex includes M tuberculosis, M bovis M africanum, and M micron Each of these species, except M micron (a cause of rodent tuberculosis), causes tuberculosis in humans Significantly, there are no environmental reservoirs of M tuberculosis complex organisms, and only a few animals (cattle and occasionally deer) transmit tuberculosis to humans Of all the culturable mycobacteπa, only M tuberculosis is an obligate pathogen M tuberculosis causes a variety of disease syndromes depending upon the site of infection The lung is the site of initial tuberculous infection and pulmonary tuberculosis remains the most common presentation, accounting for 85 % of all tuberculosis in non-HIV infected patients Pulmonary tuberculosis (TB) is the leading cause of death due to a single infectious organism in the world There are 8 to 10 million new active cases of TB each year and approximately two million deaths It is believed that one-third of the world's population, or 1 7 billion individuals, harbor latent tuberculosis (Centers for Disease Control and Prevention Tuberculosis morbidity - United States, 1997 MMWR 47(13) 253-7, 1998, Small et al , N Engl J Med 324 289 94, 1991) Leprosy is caused by M leprae, a slow growing obligate intracellular parasite The disease is believed to occur as a result of a relatively specific defect in a patient's cell mediated immune response to M leprae There are 11 to 12 million cases of leprosy worldwide, the United States has more than 5,500 Diagnosis of leprosy is based on physical findings plus skm scrapings and biopsy Skin scrapings are evaluated by smearing the material onto a microscopic slide and histological staining (see below) Once diagnosed, leprosy can be treated using a combination anti-leprosy drug therapy (Jacobson, "Leprosy," In Textbook of Internal Medicine, Kelley et al (eds ), J B Lippmcott Co , 1989, pp 1582-4) In general, a combination therapy is essential for the effective treatment of TB or MAC disease, although different agents are used to treat the different infections The identification of the species of mycobactena involved m an infection is essential to determining the treatment protocol For example, MAC organisms are resistant to many of the standard anti mycobacteπal drugs used for tuberculosis, including isoniazid, pyrazinamide, and often streptomycin The two laboratory techniques that have classically been used to detect a mycobacterial infection are the acid fast smear and cultivation of the organism In addition, techniques have been developed to determine the species of the organism (e g DNA blotting techniques) Generally, these techniques are performed on a body fluid, such as sputum and blood (Heifets and Good, "Current laboiatory methods for the diagnosis of tuberculosis," in Tuberculosis Pathogenesis, Protection and Control ASM Press, Bloom BR (ed), Washington, DC, 1994, pp 85-110) Smear examinations (such as sputum smears) are usually performed within 24 hours after the specimen is submitted Smear exams are more rapid but less sensitive than culture Smears detect 10,000 - 100,000 organisms per ml of fluid or tissue Although a negative smear does not rule out disease, it does suggest that the infection is light if it is present at all Positive smears cannot differentiate between MAC, M tuberculosis, or a host of other environmental acid-fast bacilli, and thus, they must be evaluated on the basis of the case history, as well as physical and laboratory findings The cultivation of mycobactena is time-consuming It usually takes three to four weeks to obtain colonies on standard semi-solid medium Most laboratories m the U S use the BACTEC™ radiometπc mycobacterial growth system, which detects the growth of mycobacteπa by their metabolic conversion of radioactive palmitic acid in the liquid growth medium into radioactive gaseous C0 2 The BACTEC™ system frequently yields positive cultures with 8 15 days However, the BACTEC™ system does not differentiate between M tuberculosis infection, MAC, and other slow-growing mycobacterial infections (Kent and Kubica, Public Health Mycobacteriology a Guide for the Level III Laboratory, US Dept of Health and Human Services, Atlanta, GA, 1985, Siddiqi, Radiometπc (BACTEC) tests for slowly growing mycobactena, in Clinical Microbiology Procedures Handbook, Vol 1 , Isenberg HD (ed), American Society for Microbiology, Washington, DC, 1992) This is a serious clinical problem because appropriate therapy (and the need for precautionary respiratory isolation) often depends on the species of Mycobacterium that is present Determining the Mycobacterium species present in a sample has been accomplished in the past by removing a small portion of the organism that has grown in the BACTEC™ bottle, and performing a series of DNA hybridization tests with species-specific probes The DNA probe test (e g AccuProbe Kit) takes approximately four hours and can usually be performed a few days after detection of the organism in the BACTEC™ system (Centers for Disease Control and Prevention Nucleic Acid Amplification Tests for Tuberculosis MMWR 45 950-952, 1996) Alternatively, a battery of time consuming biochemical and selective medium growth tests can be performed in order to speciate acid fast isolates However, these procedures often require growth of the bacteria, a process which is time consuming because of the slow growth of mycobacterial organisms Nucleic acid amplification methods have been used to identify M tuberculosis in a sample (e g U S Patent No 5,811 ,269, U S Patent No 5,736,365) However, there remains a need in the art for a rapid method for detecting the other species of Mycobacterium in samples, so that appropriate therapy and any necessary precautions can be initiated and/or terminated as soon as possible In addition, a need exists for a method to provide rapid identification of not just one species, but multiple species of Mycobacterium, particularly those species that are pathogenic, such as known human pathogens SUMMARY A novel method of detecting and diagnosing mycobacterial infection has been developed This method allows the identification of the species of Mycobacterium involved in an infection by detecting the presence of Mycobacterium nucleic acids in a sample with a unique solid phase nucleic acid array of Mycobacterium specific probes Both the oligonucleotides used with the method and the solid phase nucleic acid array of Mycobacterium specific probes are also disclosed A method for species-specific identification of a Mycobacterium species, is provided The method includes hybridizing a primer which is a Mycobacterium genus selective primer or a Mycobacterium specific primer to a sample, amplifying Mycobacterium specific nucleic acids from the sample utilizing the Mycobactertum-genus selective primer or the Mycobacterium specific primer to produce amplified Mycobactenum-specific nucleic acids, hybridizing the amplified Mycobacterium specific nucleic acids to a solid phase nucleic acid array comprising a plurality of Mycobacterium species specific probe oligonucleotides chemically linked to a polymeric solid support surface in a predetermined pattern, detecting a hybridization pattern of the Mycobactenum-specific nucleic acid to the Mycobacterium species specific probe oligonucleotides chemically linked to a solid support surface in a predetermined pattern, and identifying the species of Mycobacterium in the sample based on the hybridization pattern Also disclosed is a method for identifying a species of Mycobacterium present in a sample The method includes providing a plurality of single stranded Mycobacterium species-specific oligonucleotides probes chemically linked to a solid support surface m an array A Mycobacterium nucleic acid from the sample is hybridized with the array, wherein the Mycobacterium nucleic acid is in solution, and forms a hybridization complex with a species specific probe in the array The presence of the hybridization complex is detected, wherein the presence of the hybridization complex in the array indicates the species of Mycobacterium present in the sample In some embodiments, the Mvcobactertum-specific nucleic acid in the sample can be amplified prior to the hybridization step A device is also disclosed for the detection of Mycobacterium The device includes a solid phase nucleic acid array comprising a plurality of Mycobacterium species specific oligonucleotides chemically linked to a solid polymeric support surface in a predetermined pattern Mycobacterium-sipecific oligonucleotides are disclosed, which can be used as probes m the array These oligonucleotides include those that have a sequence comprising at least 15 consecutive base pairs of any one of SEQ ID NO 1 , SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4 SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10 SEQ ID NO 11 SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO 14 SEQ ID NO 15, SEQ ID NO 16 SEQ ID NO 17, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 21 , SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31 , SEQ ID NO 32, or SEQ ID NO 33 The foregoing and other objects, features and advantages of the disclosure will become more apparent from the following detailed description, which proceeds with reference to the following detailed description of several particular embodiments, as illustrated in the accompanying drawings BRIEF DESCRIPTION OF THE DRAWINGS FIG 1 is a schematic drawing showing a side view of a solid phase array, illustrating Mycobacterium o gonucleotide probes attached to a solid support FIGS 2A-2C are schematic drawings showing a top view of solid phase arrays, illustrating alternative embodiments of the pattern of Mycobacterium ohgonucleotide probes attached to a solid support FIG 2A is a linear pattern of probe oligonucleotides FIG 2B is a slot (rectangular) pattern of probe oligonucleotides FIG 2C is a circular (dot) pattern of probe oligonucleotides FIGS 3A-H shows schematic drawings of the signals obtamed using Mycobacterium detection arrays A sample known to contain a mycobacterial species was amplified using mycobacterial specific primers, and hybridized to a solid phase array A visible band (10) is shown as in each hybridization array as an 18 base pair poly-T biotm has successfully hybridized This is a control band which demonstrates that amplification and hybridization have been performed successfully FIG 3A M gordonae (12), FIG 3B M intracellulare (14) , FIG 3C M avium (16) FIG 3D M tuberculosis (18), FIG 3E M ulceran (20), FIG 3F M mannum (22), FIG 3G M kansasti (24), and FIG 3U M gastri (26) FIGS 4A-4H are schematic drawings of Mycobacterium detection arrays which demonstrate the increased signal obtained using biotmylated dCTP FIGS 4A 4D show the standard reaction with non biotin dCTP and FIGS 4E-4H show the reaction using biotm labeled dCTP FIGS 4 A and 4E, undiluted, FIGS 4B and 4F 1 10 dilution, FIGS 4C and 4G, 1 100 dilution and FIGS 4D and 4H, 1 1000 dilution SEQUENCE LISTING The nucleic and ammo acid sequences listed in the accompanying sequence listing are shown using standard letter abbreviations for nucleotide bases, and three letter code for ammo acids Only one strand of each nucleic acid sequence is shown, but the complementary strand is understood as included by any reference to the displayed strand SEQ ID NO 1 is an example of a Mycobacterium genus selective primer, such as a Mycobacterium-specific upstream primer SEQ ID NO 2 is a Mycobacterium genus selective primer SEQ ID NOS 3 9 are examples of Mycobacterium specific primers, such as downstream primers SEQ ID NOS 10-20 are Mycobacterium species-specific probes that can be used to detect M gordonae, M intracellulare-l , M ιntracellulare-2, M avmm/M paratuberculosis, M tuberculosis, M ulcerans/M mannum, M kansasti/M gastrt/M scrofulaceum, M haemophtlum, M leprae, M genavense and M xenopi, respectively SEQ ID NOS 21-33 are other Mycobactenum species specific probes which can be used to detect M fonmtum 1 , M fonuttum-lRC, M fortuιtum-2, M fonuιtum-2RC, M fortuιtum-3, M fonuιtum-3RC, M fonuιtum-4, M fortuιtum-4RC , M fortuιtum-5, M fortuitumSRC, M chelonae-1 , M chelonae-2 and M chelonae 3, respectively SEQ ID NO. 34 is the nucleic acid sequence of a Mycobacterium tuberculosis 16S rRNA gene, subspecies caprae, Genbank Accession No AJ 131120 SEQ ID NO 35 is the nucleic acid sequence of a Mycobactenum gordonae 16S πbosomal RNA gene, Genbank Accession No. AF1 15387 DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENTS I. Terms Unless otherwise noted, technical terms are used according to conventional usage Definitions of common terms in molecular biology can be found in Benjamin Lewm, Genes V, published by Oxford University Press, 1994 (ISBN 0-19-854287-9), Kendrew et al (eds ), The Encyclopedia of Molecular Biology, published by Blackwell Science Ltd , 1994 (ISBN 0-632-02182-9), and Robert A Meyers (ed ), Molecular Biology and Biotechnology a Compt ehensive Desk Reference, published by VCH Publishers, Inc. , 1995 (ISBN 1-56081-569-8) The following terms and methods are provided to better define the present disclosure, and to guide those of ordinary skill in the art in the practice of the present disclosure As used in this specification and in the appended claims, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates otherwise Thus, for example, reference to "a cell" includes a plurality of such cells and reference to "the primer" includes reference to one or more primers and equivalents thereof known to those skilled in the art, and so forth Animal: Living multicellular vertebrate organisms, a category that includes, for example, mammals and birds Antisense and Sense- Double-stranded DNA (dsDNA) has two strands, a 5' - > 3 ' strand, referred to as the plus strand, and a 3' - > 5' strand, referred to as the minus strand Because RNA polymerase adds nucleic acids in a 5' - > 3' direction, the minus strand of the DNA serves as the template for the RNA during transcription Thus, the RNA formed will have a sequence complementary to the minus strand, and identical to the plus strand (except that the base uracil is substituted for thymine) Antisense molecules are molecules that are specifically hybπdizable or specifically complementary to either RNA or the plus strand of DNA Sense molecules are molecules that are specifically hybπdizable or specifically complementary to the minus strand of DNA. Binding or stable binding: An ohgonucleotide binds or stably binds to a target nucleic acid if a sufficient amount of the ohgonucleotide forms base pairs or is hybridized to its target nucleic acid, to permit detection of that binding Binding can be detected by either physical or functional properties of the target ohgonucleotide complex Binding between a target and an ohgonucleotide can be detected by any procedure known to one skilled m the art, including functional or physical binding assays Binding can be detected functionally by determining whether binding has an observable effect upon a biosynthetic process such as expression of a gene, DNA replication, transcription, translation and the Physical methods of detecting the binding of complementary strands of DNA or RNA are well known in the art, and include such methods as DNase I or chemical footpπntmg, gel shift and affinity cleavage assays, Northern blotting, dot blotting and light absorption detection procedures For example, a method which is widely used, because it is so simple and reliable, involves observing a change m light absorption of a solution containing an ohgonucleotide (or an analog) and a target nucleic acid at 220 to 300 nm as the temperature is slowly increased If the ohgonucleotide or analog has bound to its target, there is a sudden increase m absorption at a characteristic temperature as the ohgonucleotide (or analog) and target dissociate or melt The binding between an ohgomer and its target nucleic acid is frequently characterized by the temperature (T at which 50 % of the ohgomer is melted from its target A higher T m means a stronger or more stable complex relative to a complex with a lower T m Biological Specimen: A biological specimen is a sample of bodily fluid or tissue used for laboratory testing or examination As used herein, biological specimens include all clinical samples useful for detection of microbial infection m subjects A biological specimen can be a biological fluid Biological fluids include blood, derivatives and fractions of blood such as serum, and fluids of the respiratory tract, including the oropharyngeal tract, such as sputum that has been expectorated or collected during bronchoscopy Examples of appropriate specimens for use with the current disclosure for the detection of Mycobacterium include conventional clinical samples, for instance blood or blood-fractions (e g , serum), and bronchoalveolar lavage (BAL), sputum, and induced sputum samples Techniques for acquisition of such samples are well known in the art Blood and blood fractions (e g , serum) can be prepared in traditional ways Oropharyngeal tract fluids can be acquired through conventional techniques, including sputum induction, bronchoalveolar lavage (BAL), and oral washing Obtaining a sample from oral washing involves having the subject gargle with an amount of normal saline for about 10-30 seconds and then expectorate the wash into a sample cup Appropriate tissue samples can be taken, for instance from the skin, lung or bronchial tissue Samples can be taken by biopsy or during autopsy examination, as appropriate cDNA (complementary DNA): A piece of DNA lacking internal, non-coding segments (mtrons) and transcπptional regulatory sequences cDNA can also contain untranslated regions (UTRs) that are responsible for translational control m the corresponding RNA molecule cDNA is synthesized in the laboratory by reverse transcription from messenger RNA extracted from cells Genetic Target: The terms "gene, " "genetic target" and "target nucleic acid' include both DNA and RNA. Generally, a gene is a sequence of DNA or RNA that codes for a protein A "target" sequence is a sequence to which an antisense or sense ohgonucleotide specifically hybridizes Hybridization: Oligonucleotides hybridize by hydrogen bonding, which includes Watson- Crick, Hoogsteen or reversed Hoogsteen hydrogen bonding between complementary nucleotide units For example, adenine and thymine are complementary nucleotides which base pair through formation of hydrogen bonds "Complementary" refers to sequence complementarity between two nucleotide units For example, if a nucleotide unit at a certain position of an ohgonucleotide is capable of hydrogen bonding with a nucleotide unit at the same position of a DNA or RNA molecule, then the oligonucleotides are complementary to each other at that position The ohgonucleotide and the DNA or RNA are complementary to each other when a sufficient number of corresponding positions in each molecule are occupied by nucleotide units which can hydrogen bond with each other A "hybridization complex" is formed when complementary nucleotides in a nucleic acid molecule(s) form base pairs "Specifically hybπdizable" and "complementary" are terms which indicate a sufficient degree of complementarity such that stable and specific binding occurs between the ohgonucleotide and the DNA or RNA target An ohgonucleotide need not be 100% complementary to its target DNA sequence to be specifically hybπdizable An ohgonucleotide is specifically hybπdizable when binding of the ohgonucleotide to the target DNA or RNA molecule interferes with the normal function of the target DNA or RNA, and there is a sufficient degree of complementarity to avoid non-specific binding of the ohgonucleotide to non-target sequences under conditions in which specific binding is desired, or under conditions in which an assay is performed Hybridization conditions resulting in particular degrees of stringency will vary depending upon the nature of the hybridization method of choice and the composition and length of the hybridizing DNA used Generally, the temperature of hybridization and the ionic strength (especially the Na + concentration) of the hybridization buffer will determine the stringency of hybridization Calculations regarding hybridization conditions required for attaining particular degrees of stringency are discussed by Sambrook et al (1989), chapters 9 and 11 , herein incorporated by reference For purposes of the present disclosure, "stringent conditions" encompass conditions under which hybridization will only occur if there is less than 25 % mismatch between the primer or ohgonucleotide probe and the target sequence "Stringent conditions" can be broken down into particular levels of stringency for more precise definition Thus, as used herein ' moderate stringency" conditions are those under which molecules with more than 25 % sequence variation (also termed ' mismatch") will not hybridize, conditions of ' medium stringency ' are those under which molecules with more than 15 % mismatch will not hybridize, and conditions of "high stringency ' are those under which sequences with more than 10% mismatch will not hybridize Conditions of "very high stringency" are those under which sequences with more than 5 % mismatch will not hybridize Stringent conditions are sequence-dependent and are different under different environmental parameters Generally, stringent conditions are selected to be about 5°C to 20 °C lower than the thermal melting point (T m ) for the specific sequence at a defined ionic strength and pH The T m is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe Conditions for nucleic acid hybridization and calculation of strmgencies can be found in Sambrook et al ((1989) In Molecular Cloning A Laboratory Manual, Cold Spring Harbor, New York) and Tijssen ((1993) Laboratory Techniques in Biochemistry and Molecular Biolog -Hybridization with Nucleic Acid Probes Part I, Chapter 2, Elsevier, New York) Nucleic acid molecules that hybridize under stringent conditions to a Mycobacterium 16S ribosomal subunit sequence will typically hybridize to a the selected portions of the gene under wash conditions of 2x SSC at 50°C Internal Complementarity The degree of complementarity of an ohgonucleotide probe with itself The internal complementarity of a probe determines the amount of base pairing that will occur within the sequences of the ohgonucleotide probe itself, or with an ohgonucleotide probe of the identical sequence Isolated: An "isolated' biological component (such as a nucleic acid molecule, protein or organelle) has been substantially separated or purified away from other biological components in the cell of the organism in which the component naturally occurs, t e , other chromosomal and extra chromosomal DNA and RNA, proteins and organelles Nucleic acids and proteins that have been "isolated" include nucleic acids and proteins purified by standard purification methods The term also embraces nucleic acids and proteins prepared by recombinant expression m a host cell as well as chemically synthesized nucleic acids Mammal: This term includes both human and non-human mammals Similarly, the term "subject" includes both human and veterinary subjects Medium The physical structural shape of a polymer that forms a solid support Thus, medium can generally include, but are not limited to polymer films (l e , polymers having a substantially non-porous surface), polymer filaments (e g , mesh and fabrics), polymer beads, polymer foams, polymer frits, and polymer threads Mycobacterium genus-selective primer A primer that permits amplification of nucleic acid from virtually all members of the Mycobactenum genus In one embodiment, a Mycobactenum genus selective primer includes the nucleic acid sequence shown m SEQ ID NO 1 and 2 Mycobactenum-specific primer: A primer which permits amplification of nucleic acid from selected clinically relevant mycobacterial pathogens In one embodiment, these primers amplify sequences for M gordonae, M intracellulare, M avium, M tuberculosis, M mannum and M kansasu In one embodiment, a Mycobactenum specific primer includes the nucleic acid sequence shown m SEQ ID NO 1 as the upstream primer and SEQ ID NO 2, 3, 4, 5, 6, 7, 8, or 9 as the downstream primer Mycobactenum species specific probe or probe ohgonucleotide: A probe ohgonucleotide that hybridizes to nucleic acid from a specified number of Mycobactenum species, but does not bind nucleic acid from all Mycobacterium species, under a specified set of hybridization conditions In one specific, non-limiting example, the probe binds M avtum/M paratuberculosis nucleic acid under a specific set of hybridization conditions, but does not bind nucleic acid from any other Mycobactenum under identical hybridization conditions In one embodiment, the probe ohgonucleotide hybridizes with nucleic acid from only one species of Mycobacterium (e g , M gordonae) under a specific set ol hybridization conditions, but does not hybridize with nucleic acid from any other species of Mycobacterium under identical hybridization conditions Nucleic acid sequence (or polynucleotide) : A deoxyπbonucleotide or πbonucleotide polymer in either single or double stranded form, and unless otherwise limited, encompasses known analogues of natural nucleotides that hybridize to nucleic acids in a manner similar to naturally occurring nucleotides, and includes polynucleotides encoding full length proteins and/or fragments of such full length proteins which can function as a therapeutic agent A polynucleotide is generally a linear nucleotide sequence, including sequences of greater than 100 nucleotide bases m length In one embodiment, a nucleic acid is labeled (e g biotinylated, fluorescently labeled or radiolabeled nucleotides) Nucleotide: Nucleotide includes, but is not limited to, a monomer that includes a base linked to a sugar, as in DNA and RNA, or a base linked to an ammo acid, as in a peptide nucleic acid (PNA) A nucleotide is one monomer in a polynucleotide A nucleotide sequence refers to the sequence of bases m a polynucleotide In one embodiment, nucleotides are labeled (e g biotinylated, fluorescently labeled or radiolabeled nucleotides) Ohgonucleotide: A linear polynucleotide sequence of between 10 and 100 nucleotide bases in length An ohgonucleotide can be labeled (e g using radioactive isotopes, enzyme substrates, co-factors, ligands, chemiluminescent or fluorescent agents, haptens, and enzymes) either at the 3 ' or the 5 end, or by the incorporation of labeled nucleotides into the ohgonucleotide Examples of oligonucleotides are those which are at least 15, 25, 50, 75 or 90 nucleotide bases m length Operably linked: A first nucleic acid sequence is operably linked with a second nucleic acid sequence when the first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence For instance, a promoter is operably linked to a coding sequence if the promoter affects the transcription or expression of the coding sequence Generally, operably linked DNA sequences are contiguous and, where necessary to join two protein-codmg regions, in the same reading frame Organic polymer: A support material which is in one embodiment chemically inert under conditions appropriate for biopolymer synthesis, and which comprises a backbone comprising various elemental substituents including, but not limited to, hydrogen, carbon, oxygen, fluorine, chlorine, bromine, sulfur, and nitrogen Representative polymers include, but are not limited to polypropylene, polyethylene, polybutylene, polyisobutylene, polybutadiene, polyisoprene, polyvinylpyrrohdone, polytetrafluoroe hylene, polyvinyhdene, difluoπde, polyfluoroethylene-propylene, polyethylene-vmyl alcohol, polymethypentene, polychlorotπfluoroethylene, polysulfones, and blends and copolymers thereof ORF (open reading frame) A series of nucleotide triplets (codons) coding for amino acids without any internal termination codons These sequences are usually translatable into a peptide Ortholog: Two nucleic acid or ammo acid sequences are orthologs of each other if they share a common ancestral sequence and diverged when a species carrying that ancestral sequence split into two species Orthologous sequences are also homologous sequences Polypeptide: Any chain of ammo acids, regardless of length or post-translational modification (e g , glycosylation or phosphorylation) Primers Nucleic acid primers can be readily prepared based on the nucleic acid molecules provided herein A primer comprises an isolated nucleic acid The nucleic acid can be attached to a detectable label or reporter molecule Typical labels include radioactive isotopes, enzyme substrates, co- factors, ligands, chemiluminescent or fluorescent agents, haptens, and enzymes Methods for labeling and guidance in the choice of labels appropriate for various purposes are discussed, e g , m Sambrook et al (In Molecular Cloning A Laboratory Manual, Cold Spring Harbor, New York, 1989) and Ausubel et al (In Current Protocols in Molecular Biology, Greene Publ Assoc and Wiley-Intersciences, 1992) Primers are short nucleic acid molecules, such as DNA oligonucleotides 15 nucleotides or more m length Primers can be annealed to a complementary target DNA strand bv nucleic acid hybridization to form a hybrid between the primer and the target DNA strand, and then the primer extended along the target DNA strand by a DNA polymerase enzyme Primer pairs can be used for amplification of a nucleic acid sequence, e g , by the polymerase chain reaction (PCR), or other nucleic acid amplification methods known in the art An "upstream" primer is a primer 5' to a reference point on a nucleic acid sequence A 'downstream" primer is a primer 3 to a reference point on a nucleic acid sequence In general, at least one upstream and one downstream primer are included in an amplification reaction Methods for preparing and using primers are described, for example, m Sambrook et al (In Molecular Cloning A Laboratory Manual, Cold Spring Harbor, New York, 1989) Ausubel et al (In Current Protocols in Molecular Biolog , Greene Publ Assoc and Wiley-Intersciences, 1992), and Innis et al (PCR Protocols, A Guide to Methods and Applications, Academic Press, Inc , San Diego, CA, 1990) PCR primer pairs can be derived from a known sequence, for example, by using computer programs intended for that purpose such as Primer (Version 0 5, ® 1991 , Whitehead Institute for Biomedical Research, Cambridge, MA) One of ordinary skill in the art will appreciate that the specificity of a particular primer increases with its length Thus, for example, a primer comprising 20 consecutive nucleotides of the nucleic acid encoding a Mycobacterium 16S ribosomal subunit will anneal to a target sequence, such as a Mycobacterium nucleic acid in a sputum sample, with a higher specificity than a corresponding primer of only 15 nucleotides The disclosure thus includes isolated nucleic acid molecules that comprise specified lengths of the Mycobacterium 16S ribosomal subunit gene sequences Such molecules can comprise at least 20, 25, 30, 35 or 40 consecutive nucleotides of these sequences, and can be obtained from any region of the disclosed sequences The Mycobacterium 16S ribosomal subunit gene is approximately 1450 nucleotides in length Nucleic acid molecules can be selected that comprise at least 20, 25, 30, 35 or 40 consecutive nucleotides of any of portions of the Mycobacterium 16S ribosomal subunit gene In one embodiment, nucleic acid primer oligonucleotides are selected from about base pair 100 to about base pair 600 of the Mycobacterium 16S ribosomal subunit gene Probes: Nucleic acid probes can also be readily prepared based on the nucleic acid molecules provided herein A probe comprises an isolated nucleic acid Methods for preparing and using probes are described, for example, in Sambrook et al (In Molecular Cloning A Laboratory Manual, Cold Spring Harbor, New York, 1989), Ausubel et al (In Current Protocols in Molecular Biology, Greene Publ Assoc and Wiley-Intersciences, 1992), and Inms et al (PCR Protocols, A Guide to Methods and Applications, Academic Press, Inc , San Diego, CA, 1990) One of ordinary skill in the art will appreciate that the specificity of a particular probe also increases with its length Thus, for example, a probe comprising 20 consecutive nucleotides of the nucleic acid encoding a Mycobactenum. 16S ribosomal subunit will anneal to a target sequence, such as an amplified Mycobactenum nucleic acid, with a higher specificity than a corresponding probe of only 15 nucleotides Thus, in order to obtain greater specificity, probes and primers can be selected that comprise 20, 25, 30, 35, 40 or more consecutive nucleotides of Mycobactenum 16S ribosomal subunit gene sequences The disclosure thus includes isolated nucleic acid molecules that comprise specified lengths of the Mycobacterium 16S ribosomal subunit gene sequences Such molecules can comprise at least 20, 25, 30, 35 or 40 consecutive nucleotides of these sequences, and can be obtained from any region ot the disclosed sequences The Mycobacterium 16S ribosomal subunit gene is approximately 1450 nucleotides in length Nucleic acid molecules can be selected as probe sequences that comprise at least 20, 25, 30, 35 or 40 consecutive nucleotides of any of portions of the Mycobacterium 16S ribosomal subunit gene Purified The term purified does not require absolute purity, rather, it is intended as a relative term Thus, for example, a purified protein preparation is one in which the protein is more pure than the protein in its natural environment within a cell For example, a preparation of a protein is purified such that the protein represents at least 50% of the total protein content of the preparation Similarly, a purified ohgonucleotide preparation is one in which the ohgonucleotide is more pure than in an environment comprising a complex mixture of oligonucleotides Recombinant: A recombinant nucleic acid is one that has a sequence that is not naturally occurring or has a sequence that is made by an artificial combination of two otherwise separated segments of sequence This artificial combination can be accomplished by chemical synthesis or, more commonly, by the artificial manipulation of isolated segments of nucleic acids, e g , by genetic engineering techniques Sequence identity: The similarity between two nucleic acid sequences, or two ammo acid sequences, is expressed in terms of the similarity between the sequences, otherwise referred to as sequence identity Sequence identity is frequently measured in terms of percentage identity (or similarity or homology); the higher the percentage, the more similar the two sequences are A Mycobacterium 16S ribosomal subunit, isolated from one species, and the corresponding gene sequences, will possess a relatively high degree of sequence identity to a Mycobactenum 16S ribosomal subunit, isolated from another species, when aligned using standard methods Methods of alignment of sequences for comparison are well know n the art Various programs and alignment algorithms are described in Smith & Waterman (1981) Adv Appl Math 2 482, Needleman & Wunsch (1970) J Mol Bwl 48 443, Pearson & Lipman (1988) Proc Natl Acad Sci USA 85 2444, Higgins & Sharp ( 1988) Gene, 73 237-44, Higgins & Sharp (1989) CABIOS 5 151 3, Corpet ef al (1988) Nuc Acids Res 16 10881 90, Huang et al (1992) Computer Appls Biosc 8 155-65, and Pearson et al (1994) Meth Mol Bio 24 307-31 Altschule. al (1990) 7 Mol Biol 215 403-10, presents a detailed consideration of sequence alignment methods and homology calculations The NCBI Basic Local Alignment Search Tool (BLAST) (Altschul et al , J Mol Bwl 215 403- 10, 1990) is available from several sources, including the National Center for Biological Information (NCBI, National Library of Medicine, Building 38A, Room 8N805, Bethesda, MD 20894) and on the Internet, for use in connection with the sequence analysis programs blastp, blastn, blastx, tblastn and tblastx Additional information can be found at the NCBI web site For comparisons of nucleic acid sequences, sequence identity can be determined by comparing the nucleotide sequences of two nucleic acids using the BLAST sequence analysis software, for instance, the NCBI BLAST 2 0 program gapped blastn set to default parameters (One example of such default settings would be expect = 10, filter = default, descriptions = 500 pairwise, alignments = 500, alignment view = standard, gap existence cost = 11 , per residue existence = 1 , per residue gap cost = 0 85) These methods can be used to determine sequence identity over short windows, such as over the first 600 base pairs of the Mycobactenum 16S ribosomal subunit An indication that two nucleic acid molecules are closely related is that the two molecules hybridize to each other under stringent conditions For comparisons of ammo acid sequences of greater than about 30 ammo acids, the Blast 2 sequences function is employed using the default BLOSUM62 matrix set to default parameters, (gap existence cost of 11 , and a per residue gap cost of 1) When aligning short peptides (fewer than around 30 ammo acids), the alignment should be performed using the Blast 2 sequences function, employing the PAM30 matrix set to default parameters (open gap 9, extension gap 1 penalties) Proteins with even greater identity to the reference sequence will show increasing percentage identities when assessed by this method, such as at least 70% , 75 % , 80% , 85% , 90% , 95% , 98 % , 99% sequence identity, when using gapped blastp with databases such as the nr or swissprot database Queries searched with the blastn program are filtered with DUST (Hancock and Armstrong, 1994, Comput Appl Btosci 10 67-70) Other programs use SEG When less than the entire sequence is being compared for sequence identity, homologs typically possess at least 75 % sequence identity over short windows of 10 20 ammo acids, and may possess sequence identities of at least 85%, 90%, 95% or 98% depending on their identity to the reference sequence Methods tor determining sequence identity over such short windows are described at the NCBI web site One ot skill in the art will appreciate that these sequence identity ranges are provided for guidance only, it is entirely possible that significant homologs can be obtained that fall outside of the ranges provided. Variant oligonucleotides and variant analogs: A variation of an ohgonucleotide or an ohgonucleotide analog is an ohgomer having one or more base substitutions, one or more base deletions, and/or one or more base insertions, so long as the ohgomer substantially retains the activity of the original ohgonucleotide or analog, or has sufficient complementarity to a target sequence A variant ohgonucleotide or analog may also hybridize with the target DNA or RNA , under stringency conditions as described above. A variant oligonulceotide or analog also exhibits sufficient complementarity with the target DNA or RNA of the original ohgonucleotide or analog as described above. II. Detection of M cobacteria in Clinical Specimens The system described herein is based on the conserved nature of the Mycobactenum gene encoding the 16S ribosomal subunit. Briefly, the techniques include collecting a sample, amplifying nucleic acid in the sample using primers that amplify a specific Mycobactenum sequence from more than one species of Mycobactenum gene (e.g. , 16S ribosomal subunit sequences), and identifying the Mycobactenum species present in the sample using species-specific probes for the specific Mycobacterium gene sequences (e.g. probes that identify the 16S ribosomal subunit sequences) a. Clinical Specimens Appropriate specimens for use with the current disclosure in detection of Mycobactenum include any conventional clinical samples, for instance blood or blood-fractions (e g. , serum), and bronchoalveolar lavage (BAL), sputum, and induced sputum samples Techniques for acquisition of such samples are well known in the art See, for instance, Schluger et al. (J. Exp Med. 176.1327-33, 1992) (collection of serum samples); Bigby et al. (Am Rev. Respir Dis. 133:515-8, 1986) and Kovacs et al (NEJM 318:589-93, 1988) (collection of sputum samples); and Ogmbene et al. (Am Rev. Respir Dis. 129:929-32, 1984) (collection of bronchoalveolar lavage, BAL). In addition to conventional methods, oral washing sequences (Helweg-Larsen et al , J Clin Mtcrobiol. 36.2068-72, 1998) provide a non-mvasive technique for acquiring appropriate samples to be used m nucleic acid amplification of Mycobactenum. Oral washing involves having the subject gargle with 50 cc of normal saline for 10-30 seconds and then expectorate the wash into a sample cup Serum or other blood fractions can be prepared in the conventional manner About 200 μL of serum is an appropriate amount for the extraction of DNA for use in amplification reactions See also, Schluger et al , J Exp Med 176 1327-33, 1992 Ortona et al , Mol Cell Probes 10 187-90, 1996 Once a sample has been obtained, the sample can be used directly, or concentrated (e g by centrifugation or filtration) and an amplification reaction performed Alternatively, the nucleic acid can be extracted using any conventional method prior to amplification For example, rapid DNA preparation can be performed using a commercially available kit (e g , the InstaGene Matrix BioRad, Hercules, CA, the NuchSens isolation kit, Organon Teknika, Netherlands) In one embodiment, the DNA preparation technique chosen yields a nucleotide preparation that is accessible to, and amenable to, nucleic acid amplification b. Amplification of Mycobactenum nucleic acid Mycobactenum nucleic acid can be amplified from target Mycobacterium gene sequences from the clinical sample prior to detection In one embodiment, DNA sequences are amplified In another embodiment, RNA sequences are amplified Any nucleic acid amplification method can be used In one specific, non-limiting example, polymerase chain reaction (PCR) is used to amplify the mycobacterial nucleic acid sequences In another specific, non-limiting example, RT PCR can be used to amplify the Mycobacterium nucleic acid sequences In a third specific, non limiting example, transcription-mediated amplification (TMA) can be used to amplify the mycobacterial nucleic acid sequences In one embodiment UTP is used in any amplification protocols In another embodiment, the target Mycobacterium nucleic acid sequences are the sequences of the Mycobactenum 16S ribosomal subunit In one embodiment, the target sequence for amplification is the region from about base pair 100 to about base pair 600 of a Mycobactenum 16S ribosomal gene (e g , Genbank Accession No AJ131120, herein incorporated by reference, SEQ ID NO 34) In one specific non-limiting example, the region form about base pair 132 to about base pair 582 of the Mycobactenum 16S ribosomal subunit gene is the target sequence for amplification In another specific, non-limiting example, the region from about base pair 123 to about base pair 573 is the target sequence for amplification (e g Genbank Accession No AF115387, M gordonae, herein incorporated by reference, SEQ ID NO 35) It should be noted that the sequence from about nucleotide 507 to about nucleotide 603 is identical in M tuberculosis, M bovis, M Bovts BCG, M avium, M intracellulare, M Kansasu, M gastn, M Parptuberculosis, M malmoesne, M szugai, M gordonae, M leprae, M ulcerans, M astaticum, and M scrofulaceum The identity of these sequences allows - 11 primers from this region to be used to amplify all of these species of Mycobactena with the same primers A pair of primers are utilized in the amplification reaction One or both of the primers can be end-labeled (e g radiolabeled, fluoresceinated, or biotinylated) The pair of primers includes an upstream primer (which binds 5 ' to the downstream primer) and a downstream primer (which binds 3 ' to the upstream primer) In one embodiment, either the upstream primer or the downstream primer is labeled One specific, non-limiting example of a primer label is a biotinylated downstream primer In one embodiment, the pair of primers used m the amplification reaction are Mycobactenum- genus selective primers, which permits amplification of nucleic acid from virtually all members of the Mycobacterium genus Specific non-hmiting examples of Mycobacterium genus selective primers that bind to Mycobacterium 16S ribosomal subunit gene sequences include 5'-ggg-ata-agc-ctg-gga-aac-tgg gtc 3' (Myco.up, SEQ ID NO 1) and 5'-BIOTIN-ccc-tct-cag-gcc-ggc-tac-ccg-3 ' (Myco dwn-Bio, SEQ ID NO 2) In one embodiment, the pair of primers used in the amplification reaction are Mycobactenum specific primers which permit amplification of nucleic acid from the most clinically relevant mycobacterial pathogens Specific non-hmitmg examples of Mycobactenum-specific primers that bind to Mycobacterium 16S ribosomal subunit gene sequences include upstream primer SEQ ID NO 1 and downstream primers 5'-BIOTIN -cta-ccg-tca-atc-cga-gag-aac-ccg-3 ' (MycoTB-Bio, SEQ ID NO 3), 5'-BIOTIN -cta-ccg-tca-gcc-cga-gaa-aac-ccg-3 ' (MycoGOR-Bio, SEQ ID NO 4), 5'-BIOTIN -cta- ccg-tca-cca-cga-gaa-aac-ccg-3 ' (MycoXEN-Bio, SEQ ID NO 5), 5' BIOTIN -cta-ccg-tca-atc cga-gaa aac-ccg-3' (MycoMAC-Bio, SEQ ID NO 6), 5' -BIOTIN -ggt-ttc-acg-aac-aac gcg aca aac cac-c 3' (MycoGENA 1-Bιo, SEQ ID NO 7), 5 '-BIOTIN -ttc-acg-aac-aac-gcg-aca-aac-cac-c-3' (MycoGENA.2-Bιo, SEQ ID NO 8) and 5'-BIOTIN -cta-ccg-tca-atc-cga-gaa-aac-cca-g-3' (MycoLEPR-Bio, SEQ ID NO 9) An additional pair of primers can be included in the amplification reaction as an internal control These primers are designed to amplify nucleic acid from all samples, and serve to provide confirmation of appropriate amplification One of skill m the art will readily be able to identify primer pairs to serve as internal control primers Alternatively, a target nucleic acid including primer hybridization sites can be constructed and included on the amplification reactor These target sequences serves as a control for amplification when appropriate primers are added to the amplification reaction A target probe is then included m the Mycobacterium detection array to detect the efficiency of the amplification reaction and the appropriateness of the hybridization conditions c. Arrays for detection of Mycobacterium nucleic acid sequences Arrays can be used to detect the presence of amplified specific Mycobacterium sequences, such as 16S ribosomal subunit sequences, using specific ohgonucleotide probes The arrays herein termed "Mycobactenum detection arrays," are used to detect the presence of Mycobacterium A predetermined set of ohgonucleotide probes are attached to the surface of a solid support for use in detection of the amplified Mycobacterium nucleic acid sequences (for example, see FIG 1) Additionally, if an internal control nucleic acid sequence was amplified in the amplification reaction (see above), an ohgonucleotide probe can be included to detect the presence of this amplified nucleic acids The oligonucleotides specifically bind sequences amplified in the amplification reaction Thus, sequences of use with the method, when 16S ribosomal subunit nucleic acid sequences are amplified, are ohgonucleotide probes that recognize the 16S ribosomal subunit nucleic acid from only one species of Mycobacterium. Such sequences can be determined by examining the sequences of the different species, and choosing primers that specifically anneal to a particular species, but not others One of skill in the art will be able to identify other Mycobacterium ohgonucleotide probes that can be attached to the surface of a solid support for the detection of other amplified Mycobactenum nucleic acid sequences (e g Mycobacterium DNA sequences) The methods and apparatus in accordance with the present disclosure takes advantage of the fact that under appropriate conditions oligonucleotides form base-paired duplexes with oligonucleotides which have a complementary base sequence The stability of the duplex is dependent on a number of factors, including the length of the oligonucleotides, the base composition, and the composition of the solution in which hybridization is effected. The effects of base composition on duplex stability may be reduced by carrying out the hybridization m particular solutions, for example in the presence of high concentrations of tertiary or quaternary amines The thermal stability of the duplex is also dependent on the degree of sequence similarity between the sequences By carrying out the hybridization at temperatures close to the anticipated T m 's of the type of duplexes expected to be formed between the target mateπal(s) and the oligonucleotides bound to the array, the rate of formation of mis-matched duplexes may be substantially reduced The length of each probe sequence employed in the array can be selected to optimize binding of target Mycobactenum nucleic acid sequences An optimum length for use with a particular Mycobacterium nucleic acid sequence under specific screening conditions can be determined empirically Thus, the length for each individual element of the set of Mycobactenum probe sequences compπsmg the array can be optimized for screening. In one embodiment, the Mycobactenum probes are from about 20 to about 35 nucleotides m length In another embodiment, the Mycobactenum ohgonucleotide probes are from about 25 to about 40 nucleotides in length The sequences forming the array can be directly linked to the support Alternatively, the Mycobacterium ohgonucleotide probes can be attached to the support by non-Mycobactenum sequences such as oligonucleotides or other molecules that serve as spacers or linkers to the solid support. In one embodiment, the probe oligonucleotides in the array are probes for Mycobacterium 16S ribosomal subunit nucleic acids. Specific, non-hmitmg example of ohgonucleotide probes for Mycobacterium 16S ribosomal subunit nucleic acids include, but are not limited to. 3 '-tc-ctg-tac-aca- gga-cac-cag-gat-aag-cc-5' which can be used to detect M. gordonae (SEQ ID NO: 10), 3'-tt-tct-gta-cgc- gga-ttt-cca-gga-tag-5 ' which can be used to detect M. intracellulare- 1 (SEQ ID NO. 11); 3'-tt-tct-gta- cgc-aga-ttt-cca-gga-tag-5' which can be used to detect M. ιntracellulare-2 (SEQ ID NO: 12); 3 ' -t-ctt- ctg-tac-gca-gaa-ctc-cag-gat-5 ' which can be used to detect M. avium/M. paratuberculosis (SEQ ID NO: 13); 3 '-gat-ttc-gcg-aaa-ggt-ggt-gtt-ctg-5' which can be used to detect M. tuberculosis (SEQ ID NO: 14); 3 '-ggt-gtc-ctg-tac-tta-ggg-cac-cag-5' which can be used to detect M. ulcerans/M. mannum (SEQ ID NO: 15); 3'-gtt-ccg-tac-gcg-gtt-cac-cag-gat-5' which can be used to detect M. kansasn/M. gastn/M. scrofulaceum (SEQ ID NO: 16) 3'-cgt-acg-cgg-aac-tcc-agg-ata-ggc-5' which can be used to detect M. haemophilum (SEQ ID NO: 17); 3'-gtg-ttc-tgt-acg-cgg-aac-ttc-agg-5' which can be used to detect M. leprae (SEQ ID NO: 18); 3'-gtt-ttg-tac-gca-agg-cac-cag-tat-agg-5' which can be used to detect M. genavense (SEQ ID NO: 19); and 3'-ggt-gta-cgc-gtc-tta-cca-gga-tag-gc-5' which can be used to detect M. xenopi (SEQ ID NO: 20) Other suitable probes include, but are not limited to: 5'-gaa-tat-gac-cgc-gct-ctt-cat-ggg-gtg-tg- 3' which can be used to detect M. fortuttum-l (SEQ ID NO: 21); 5'-ca-cac-ccc-atg-aag-agc-gcg-gtc-ata- ttc-3 ' which can be used to detect M. fonuitum-lRC (SEQ ID NO: 22); 5'-gaa-tat-gac-cac-gcg-ctt-cat- ggt-gtg-tg-3 ' which can be used to detect M. fortuιtum-2 (SEQ ID NO: 23); 5'-ca-cac-acc-atg-aag-cgc- gcg-gtc-ata-ttc-3 ' which can be used to detect M. fonuιtum-2RC (SEQ ID NO: 24); 5'-gaa-tat-gac-cgc- gca-ctt-cct-ggt-gtg-tg-3 ' which can be used to detect M. fonuιtum-3 (SEQ ID NO: 25); 5'-ca-cac-acc- agg-aag-tgc-gcg-gtc-ata-ttc-3 ' which can be used to detect M. fortuιtum-3RC (SEQ ID NO: 26); 5'-gaa- tat-gac-cgc-gca-ctt-cct-ggt-gtg-tg-3' which can be used to detect M. fonuιtum-4 (SEQ ID NO: 27); 5'- ca-cac-acc-agg-aag-tgc-gcg-gtc-ata-ttc-3' which can be used to detect M. fortuιtum-4RC (SEQ ID NO: 28); 5'-gga-tag-gac-cac-gcg-ctt-cat-ggt-gtg-tg-3 ' which can be used to detect M. fonuιtum-5 (SEQ ID NO: 29); 5'-ca-cac-acc-atg-aag-cgc-gtg-gtc-cta-tcc-3 ' which can be used to detect M. fonuttumSRC (SEQ ID NO: 30); 5'-gaa-cgg-aaa-ggc-cct-tcg-ggg-tac-t-3 ' which can be used to detect M. chelonae-l (SEQ ID NO 31), 5'-gaa-cgg-aaa-ggc-ttc-ggg-gta-ctc-g-3' which can be used to detect M. chelonae-2 (SEQ ID NO 32), and 5'-gaa-cgg-aaa-ggc-cct-tcg-ggg-tgc-t-3' which can be used to detect M chelonae-3 (SEQ ID NO: 33) The solid support can be formed from an organic polymer Suitable materials for the solid support include, but are not limited to- polypropylene, polyethylene, polybutylene, polyisobutylene, plybutadiene, polyisoprene, polyvmylpyrrolidine, polytetrafluroethylene, polyvmyhdene difluroide, polyfluoroefhylene-propylene, polyethylenevmyl alcohol, polymethylpentene, polycholorotπfluoroethylene, polysulfornes, hydroxylated biaxially oriented polypropylene, animated biaxially oriented polypropylene, thiolated biaxially oriented polypropylene, etyleneacryhc acid, thylene methacryhc acid, and blends of copolymers thereof (see U S Patent No 5,985,567, herein incorporated by reference) In general, suitable characteristics of the material that can be used to form the solid support surface include being amenable to surface activation such that upon activation, the surface of the support is capable of covalently attaching a biomolecule such as an ohgonucleotide thereto; amenability to "in situ" synthesis of biomolecules, being chemically inert, such that at the termination of biomolecular synthesis, areas on the support not occupied by the biomolecules are not amenable to nonspecific binding, or when non-specific binding occurs, such materials can be readily removed from the surface without removing the biomolecules In one embodiment, the solid support surface is polypropylene Polypropylene is chemically inert and hydrophobic Non-specific binding is generally avoidable, and detection sensitivity is improved. Polypropylene has good chemical resistance to a variety of organic acids (l e , formic acid), organic agents (i.e. acetone or ethanol), bases (i.e. sodium hydroxide), salts (i.e sodium chloride), oxidizing agents (l e peracetic acid), and mineral acids (l e hydrochloric acid) Polypropylene also provides a low fluorescence background, which minimizes background interference and increases the sensitivity of the signal of interest A surface activated organic polymer can be the solid support surface. In one specific non- limiting example, the surface activated organic polymer is a polypropylene material animated via radio frequency plasma discharge Such materials are easily utilized for the attachment of nucleotides, and thus are well suited for ohgonucleotide synthesis The amme groups on the activated organic polymers are reactive with nucleotides such that the nucleotides can be bound to the polymers Alternatively, other reactive groups can be used (e g , carboxylated, hydroxylated, thiolated, or active ester groups) A wide variety of array formats can be employed in accordance with the present disclosure One example includes a linear array of ohgonucleotide bands, generally referred to m the art as a dipstick (see FIG 2A and FIGS 3A-3H) Another suitable format comprises a two dimensional pattern of discrete cells (e g , 4096 squares in a 64 by 64 array, see also FIGS 2A-2C) As would be readily appreciated by those skilled in the art, other array formats including, but not limited to slot (rectangular) (FIG 2B) and circular (FIG 2C) arrays are equally suitable for use (see U S Patent No 5,981 , 185, herein incorporated by reference) In one embodiment, the array is formed on a polymer medium, which is a thread, membrane or film An example of an organic polymer medium is a polypropylene sheet having a thickness on the order of about 1 mil (0 001 inch) to about 20 mil although the thickness of the film is not critical and can be varied over a fairly broad range Particularly disclosed for preparation of arrays at this time are biaxially oriented polypropylene (BOPP) films, in addition to their durability, BOPP films exhibit a low background fluorescence The array formats of the present disclosure can be included in a variety of different types of formats A "format" includes any format to which the solid support can be affixed, such as micro titer plates, test tubes, inorganic sheets, dipsticks, etc For example, when the solid support is a polypropylene thread, one or more polypropylene threads can be affixed to a plastic dipstick-type device, polypropylene membranes can be affixed to glass slides The particular format is, m and of itself, unimportant All that is necessary is that the solid support can be affixed thereto without affecting the functional behavior of the solid support or any biopolymer absorbed thereon, and that the format (e g the dipstick or slide) is stable to any materials into which the device is introduced (e g clinical samples, hybridization solutions, etc ) The arrays of the present disclosure can be prepared by a variety of approaches which are known to those working in the field Pursuant to one type of approach, the complete ohgonucleotide probe sequences are synthesized separately and then attached to a solid support (see U S Patent No 6,013,789, herein incorporated by reference) In another embodiment, the sequences can be synthesized directly onto the support to provide the desired array (see U S Patent No 5,554,501 , herein incorporated by reference) Suitable methods for covalently coupling oligonucleotides to a solid support and for directly synthesizing the oligonucleotides onto the support would be readily apparent to those working in the field, a summary of suitable methods can be found m Matson et al , Anal Biochem 217 306-10, 1994 In one embodiment, the oligonucleotides are synthesized onto the support using conventional chemical techniques for preparmg oligonucleotides on solid supports (e g , see PCT applications WO 85/01051 and WO 89/10977, or U S Patent No 5,554,501 , herein mcorporated by reference) In one specific, non-hmiting example, a polypropylene support (for example, a BOPP) is first surface animated by exposure to an ammonia plasma generated by radiofrequency plasma discharge The reaction of a phosphoramidite-activated nucleotide with the animated membrane followed by oxidation with, e g , iodine provides a base stable amidate bond to the support A suitable array can be produced using automated means to synthesize oligonucleotides m the cells of the array by laying down the precursors for the four bases in a predetermined pattern Briefly, a multiple-channel automated chemical delivery system is employed to create ohgonucleotide probe populations in parallel rows (corresponding m number to the number of channels in the delivery system) across the substrate Following completion of ohgonucleotide synthesis in a first direction, the substrate can then be rotated by 90° to permit synthesis to proceed within a second (2°) set of rows that are now perpendicular to the first set This process creates a multiple-channel array whose intersection generates a plurality of discrete cells The oligonucleotides can be bound to the polypropylene support b either the 3 ' end of the ohgonucleotide or by the 5' end of the ohgonucleotide In one embodiment, the oligonucleotides are bound to the solid support by the 3' end However, one of skill in the art will be able to determine whether the use of the 3 ' end or the 5 ' end of the ohgonucleotide is suitable for bonding to the solid support In general, the internal complementarity of an ohgonucleotide probe m the region of the 3 ' end and the 5' end determines binding to the support. In general, the end of the probe with the most internal complementarity is bound to the support, thereby leaving the end with the least internal complementarity to bind to amplified Mycobacterium sequences d. Detection of Mycobacterium nucleic acid In one embodiment, the ohgonucleotide probes used m an amplification reaction are labeled (e.g biotin labeled, radiolabeled, or enzymatically labeled) Alternatively, the amplified nucleic acid samples are end-labeled to form labeled amplified material In one embodiment, the amplified mycobacterial nucleic acid is labeled by including labeled nucleotides in the amplification reactions Methods for labeling nucleic acids are well known to one of skill m the art For example, conventional methods for end-labeling nucleic acids are employed following the amplification reaction Radioactive and fluorescent labeling methods, as well as other methods known in the art, are suitable for use with the present disclosure The labeled amplified Mycobactenum nucleic acid is applied to the Mycobactenum probe array under suitable hybridization conditions to form a hybridization complex In one embodiment a pre- treatment solution of organic compounds, solutions that include organic compounds, or hot water, can be applied before hybridization (see U.S Patent No 5,985,567, herein incorporated by reference). Hybπdization conditions for a given combination of array and target material can be optimized routinely in an empirical manner close to the T m of the expected duplexes, thereby maximizing the discriminating power of the method Identification of the location m the array, such as a cell, in which binding occurs, permits a rapid and accurate identification of Mycobacterium sequences present in the amplified material (see below) The hybridization conditions are selected to permit discrimination between matched and mismatched oligonucleotides Hybridization conditions can be chosen to correspond to those known to be suitable in standard procedures for hybridization to filters and then optimized for use with the arrays of the disclosure For example, conditions suitable for hybridization of one type ot target would be adjusted for the use of other targets for the array In particular, temperature is controlled to substantially eliminate formation of duplexes between sequences other than exactly complementary Mycobactenum sequences A variety of known hybridization solvents can be employed, the choice being dependent on considerations known to one of skill m the art (see U.S Patent 5,981 , 185, herein incorporated by reference) The developing and detecting of a hybridized complex in an array of ohgonucleotide probes have been previously described (see U.S. Patent No 5,985,567, herein incorporated by reference) Briefly, developing and detection can include the steps of treating the hybridized complex with a conjugating solution, and treating the conjugated, hybridized complex with a detection reagent Once the amplified Mycobactenum nucleic acid has been hybridized with the oligonulceotide probes present in the Mycobacterium detection array the presence of the hybridization complex is detected The developing and detection can include the use of a detection label The detection label is used to detect the signal of interest, and may be a radiolabel or a non- radiolabel Non-radiolabels include, but are not limited to an enzyme, chemiluminescent compound, fluorescent compound, metal complex, hapten, enzyme, coloπmetπc agent, or a dye. The developing can include applying a buffer In one embodiment, the buffer is sodium salme citrate, sodium salme phosphate, tetramethylammonmm chloride, sodium salme citrate m ethylenediaminetetra- acetic, sodium saline citrate in sodium dodecyl sulfate, sodium saline phosphate m ethylenediaminetetra- acetic, sodium salme phosphate in sodium dodecyl sulfate, tetramethylammonium chloride in ethylenediaminetetra- acetic, tetramethylammonium chloride in sodium dodecyl sulfate, or combinations thereof However, other suitable buffer solutions may also be used The developing and detecting step can further include the steps of treating the hybridized complex with a conjugating solution, and treating the conjugated, hybridized complex with a detection reagent However, these steps do not need to be carried out when radiolabels are used with the target biomolecules The hybridized complex can be treated after hybridization with a conjugating solution to eftect conjugation or coupling of the hybridized complex with the detection label In one embodiment, the conjugating solution comprises streptavidm alkaline phosphatase, avidm alkaline phosphatase, or horseradish peroxidase Specific, non-hmitmg examples of conjugating solutions include streptavidm alkaline phosphatase, avidin alkaline phosphatase, or horseradish peroxidase The conjugated, hybridized complex can be treated with a detection reagent In one embodiment, the detection reagent comprises enzyme-labeled fluorescence reagents or caloπmetπc reagents In one specific non-hmitmg example, the detection reagent is enzyme-labeled fluorescence reagent (ELF) from Molecular Probes, Inc , Eugene, OR The hybridized complex can then be placed on a detection device, such as an ultraviolet (UV) transilluminator (manufactured by UVP, Inc of Upland, CA) The signal is developed and the increased signal intensity may be recorded with a recording device, such as a charge coupled device (CCD) camera (manufactured by Photometries, Inc of Tucson, AZ) e. Kits The present disclosure also provides for a kit for identifying the species of Mycobactenum present in a sample In one embodiment, the kit includes a Mycobactenum detection array, a buffer solution, a conjugating solution for developing the signal of interest, and a detection reagent for detecting the signal of interest, each in separate packaging, such as a container In another embodiment, the kit includes a plurality of Mycobactenum target nucleic acid sequences for hybridization with a Mycobacterium detection array to serve as positive control The target nucleic acid sequences can include oligonucleotides such as deoxyπbonucleic acid, πbonucleic acid, and peptide nucleic acid, or may comprise polymerase chain reaction fragments The kit can also optionally include an effective amount of a pre-treatment solution for application to the probe biomolecules to produce an amplified signal EXAMPLES Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present disclosure to its fullest extent The following examples are illustrative only, and not limiting of the disclosure m any way whatsoever EXAMPLE 1 DETECTION OF MYCOBACTERIUM NUCLEIC ACID IN A SAMPLE A successful detection and identification of a pathogenic species ot mycobactena in a subject's respiratory samples were achieved a using the device of the disclosure and the mycobacteπa-specific primers disclosed herein One upstream primer and four downstream primers were used for PCR amplification of nucleic acids in a patient sample as follows upstream primer SEQ ID NO 1 and four downstream primers MycoTB-Bio (SEQ ID NO 3), MycoGOR-Bio (SEQ ID NO 4) MycoXEN-Bio (SEQ ID NO 5), and MycoMAC-Bio (SEQ ID NO 6) The following conditions were used for the PCR amplification reaction 10X PCR Buffer (final concentration IX), 2 5 mM MgCl,, 2 5 mg/ml BSA, 1 U UNG, 2 5 U Taq, 0 2 mM each dATP, dGTP, dCTP, 0 4 mM dUTP, 50 pmol each SEQ ID NO 1 , MycoTB-BIO (SEQ ID NO 3), MycoGOR-BIO (SEQ ID NO 4), MycoXEN-BIO(SEQ ID NO 5), and MycoMAC-BIO (SEQ ID NO 6) A 50 μl reaction was prepared Other reaction volumes can also be prepared (e g 25, 20, or 5 μl reactions) Alternatively, the following genus-selective primers were used SEQ ID NOS 1 and 2 under identical PCR conditions as described above, except that 50 pmol each SEQ ID NOS 1 and 2 were used instead of the primers listed above With both sets of primers, the following amplification cycling protocol was used 20 °C for 10 minutes, 94°C for 2 minutes, then 35 cycles of 94°C for 1 minute, 65°C for 30 seconds, and 72°C for 30 seconds This was followed by 72°C for 10 minutes and a hold at 4°C A PCR product was obtained using a concentrated sputum sample obtained from a subject, which was positive for acid-fast bacilli The amplification products were hybridized to a Mycobacterium detection array including the probe sequences shown in SEQ ID NOS 10-16 The following hybridization procedure was used The following components were added to a microfuge tube and inverted several times to mix 950 μl 2x SSPE, 0 01 % SDS, 50 μl PCR product (biotinylated), and 2 μl biotinylated dTTP-18 (0 01 μg/μl poly-T ohgonucleotide, or 0 2 μg per reaction, which serves as a positive control) The Mycobactenum detection array in a strip form was trimmed and inserted into microfuge tube The tube was placed m boiling water bath for two minutes then mmediately placed in a 50 °C heat block for one hour The strip was transferred to a 50 ml Falcon tube containing 20-30 ml 2X SSC, 0 01 % SDS and washed for five minutes with gentle agitation A mixture of 990 μl 2X SSC and 10 μl TROPIX (prepared immediately prior to use) was pipetted into a microfuge tube and inverted several time to mix The hybridized strip was placed into the tube and incubated for approximately one hour at room temperature (RT) with gentle agitation The hybridized strip was washed three times, 5 minutes per wash, with 20 30 ml 2X SSC, 0 01 % SDS in a 50 ml Falcon tube with gentle agitation ELF Component B (760 μl) was pipetted into a microfuge tube and 40 μl ELF Component A was added, and inverted several times to mix These components are part of a commercially available reagent kit, and were prepared immediately prior to use The strip was inserted into the microfuge tube and incubated for 30 minutes at RT (without agitation) The strip was rinsed briefly in 2X SSC buffer and signal was detected on the UV transillummator box In this assay system the mycobacterial detection array showed the presence of nucleic acid correspondmg to Mycobacterium avium Another aliquot of the concentrate tested negative for Mycobacterium tuberculosis with the commercially available GenProbe MTD test The identification of the acid-fast bacillus in the sample as M avium was subsequently confirmed by a standard mycobacteriology work up EXAMPLE 2 SPECIFICITY Five additional mycobacterial species were tested using the protocol descπoed m Example 1 The species tested, M gordonae, M intracellulare, M avium, M tuberculosis, M mannum and M kansasu, collectively constitute about 90% of the patient isolates detected in many clinical mycobacteriology lab sections To achieve specific hybridization of the PCR products from all these species, different variations of hybridization conditions were tested with the Mycobacterial detection array In FIGS 3A-H a visible band (10) is shown as m each hybridization array as an 18 base pair poly-T biotin has successfully hybridized This is a control band which demonstrates that amplification and hybridization have been performed successfully Specific hybridization reactions were demonstrated with nucleic acids amplified from known samples of M gordonae, M intracellulare, M avium, M tuberculosis, M mannum, and M kansasu A single solid band lit up on each strip below the bright poly- A control band The strips show each PCR product FIGS 1A-1H show a mycobacterium PCR product hybridizing only to its unique detection band as follows M gordonae (FIG 3A, probe line 12), M intracellulare from one isolate type (FIG 3B, probe line 14), M avium (FIG 3C probe line 16), M tuberculosis (FIG 3D, probe line 18) M ulcerans (FIG 3E M ulcerans/M mannum probe line 20), M mannum (FIG 3F, M ulcearans/M mannum probe line 22) M kansasu (FIG 3G, M kansasulM gastri probe line 24), and M gastri (FIG 3H M kansasu/M gastri probe line 26) EXAMPLE 3 SIGNAL AMPLIFICATION USING dCTP-BIOTIN The use of dCTP biotm in the PCR amplifications was tested to determine if a greater signal is generated for a given amount of PCR product Results with the Mycobacterium genus-selective primers PCR amplification products using the protocol shown in Example 1 showed approximately a 10-fold signal increase with a consequent similar reduction in the limit of detection with the strips Similarly, the use of the dCTP-biotm assay modification with the mycobactena-specific primer set shown m Example 1 also resulted in a 10-fold signal increase PCR was performed using the same amount of M tuberculosis DNA as a template Reaction I used the standard four nucleotides and one primer with biotin attached (FIGS 4A-4D) Reaction II used biotin-labeled dCTP in the nucleotide mix (FIGS 4E-4H) Two sets ot tour the Mycobacterium detection arrays were incubated with various dilutions of two amplification products from reactions using the same amount of M tuberculosis DNA (see FIGS 4A-4H) Ten-fold dilution series were made of each reaction (1 10 (FIGS 4B and 4F), 1 100 (FIGS 4C and 4G) and 1 1 ,000 (FIGS 4D and 4H)) and hybridized to Mycobacterium detection arrays, which were then developed At each dilution the intensity of the band seen with the dCTP-biotin modification (bands 34, 36, and 38 in FIGS 4E, 4F, and 4G, respectively) is clearly stronger than the corresponding band with the standard method (bands 30 and 32 in FIGS 4A and 4B, respectively) In the dCTP biotin series there is a famt band visible at the 1 1 ,000 dilution, while none is observed with the corresponding 1 1 ,000 dilution of the standard product This suggests that the dCTP-biotin modification increases the sensitivity of the assay system by ten-fold Having illustrated and described the principles of the present disclosure by several specific examples, it should be apparent to one skilled in the art that the disclosure can be modified in arrangement and detail without departing from such principles In view of the many possible embodiments to which the principles of our disclosure can be applied, it should be recognized that the illustrated embodiments are only examples of the disclosure and should not be taken as a limitation on the scope of the disclosure Rather, the scope of the disclsoure is in accord with the following claims We therefore claim as our invention all that comes within the scope and spirit of these claims

Claims: We claim 1 A method tor species-specific identification of a bacteria, comprising hybridizing a primer which is a bacterial genus selective primer or a bacterial specific primer to a sample, amplifying bacterial-specific nucleic acids from the sample utilizing the bacterial-genus selective primer or the bacterial specific primer to produce amplified bacterial- specific nucleic acids, hybridizing the amplified bacterial specific nucleic acids to a solid phase nucleic acid array comprising a plurality of bacterial species specific probe oligonucleotides chemically linked to a polymeric solid support surface in a predetermined pattern, detecting a hybridization pattern of the bacterial specific nucleic acid to the bacterial species specific probe oligonucleotides chemically linked to a solid support surface m a predetermined pattern, and identifying the species of bacteria in the sample based on the hybridization pattern 2 The method of claim 1 , wherein the bacteria is Mycobacterium 3 The method of claim 1 , wherein the amplification utilizes polymerase chain reaction (PCR), reverse trasncπptase-polymerase chain reaction (RT-PCR) or transcription mediated amplification (TMA) 4 The method of claim 3 , wherein the amplification utilizes RT-PCR 5 The method of claim 2, wherein the primer is a Mycobactenum-genus selective primer that has a sequence as set forth as SEQ ID NO 1 or SEQ ID NO 2 6 The method of claim 2, wherein the primer is a Mycobacterium specific primer that has a sequences as set forth as SEQ ID NO 1 , SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, or SEQ ID NO 9 7 The method of claim 2, wherein the Mycobactenum species specific probe oligonucleotides each have a 3 ' and a 5' end, and wherein at least one of the Mycobacterium species specific probe oligonucleotides is attached to the solid support surface by the 3 ' end of the probe ohgonucleotide 8 The method of claim 1 , wherein the polymeric solid support is a polypropylene solid support 9 The method of claim 2, wherein the identification comprises comparing the hybridization pattern to a control pattern m order to identify the species of Mycobacterium m the sample 10 The method of claim 2, wherein at least one of the Mycobactenum species specific probe oligonucleotides attached to the solid support surface has a sequence as set forth as SEQ ID NO 10, SEQ ID NO 11, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 17, SEQ ID NO 18, SEQ ID NO 19 SEQ ID NO 20, SEQ ID NO 21 , SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31 , SEQ ID NO 32, or SEQ ID NO 33 11 The method of claim 1 , wherein the Mycobacterium species comprises M gordonae, M intracellulare, M avium, M tuberculosis, M mannum, or M kansasu 12 The method of claim 2, wherein the amplified Mycobactenum specific nucleic acids are labeled nucleic acids 13 The method of claim 12, wherein the labeled nucleic acid is biotm labeled nucleic acid 14 The method of claim 13, wherein the detection comprises contacting the hybridized solid phase nucleic acid array with a avidm linked to a detectable reagent 15 The method of claim 14, wherein the detectable reagent is a fluorescent reagent or a radio-labeled reagent 16 A method tor identifying a species of Mycobactenum present in a sample, comprising hybridizing a plurality of single stranded Mycobacterium species specific ohgonucleotide probes chemically linked to a solid support surface in an array with a Mycobacterium-specific nucleic acid from the sample, wherein the Mycobactenum specific nucleic acids are in solution, to form a hybridization complex, and detectmg the presence of the hybridization complex, wherein the presence of the hybridization complex m the array indicates the species of Mycobacterium present m the sample 17 The method of claim 16, further comprising amplifying the Mycobactenum specific nucleic acid in the sample prior to the hybridization step 18 The method of claim 16, wherein the amplification is polymerase chain reaction (PCR), reverse transcπptase-polymerase chain reaction (RT-PCR) or transcription mediated amplification (TMA) 19 The method of claim 18, wherein the amplification is PCR amplification 20 The method of claim 16, wherein the PCR amplification comprises hybridization with an ohgonucleotide having a nucleic acid sequence as set forth as SEQ ID NO 1 , SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, or SEQ ID NO 9, or at least 15 contiguous nucleotides of any of these sequences 21 The method of claim 16, wherein the solid support surface is a polymeric surface 22 The method of claim 21 , wherein the polymeric surface is a polypropylene surface 23 The method of claim 16, wherein each Mycobacterium species specific ohgonucleotide probe has a 5 and a 3 end, and wherein at least one of the Mycobactenum species specific ohgonucleotide probes is chemically linked to the solid support surface by the 3 end 24 The method of claim 16, wherein at least one of the Mycobactenum species specific oligonucleotides attached to the solid support surface has a sequence as set forth as SEQ ID NO 10, SEQ ID NO 11 , SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO 14 SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 17, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 21 , SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31 , SEQ ID NO 32, or SEQ ID NO 33 25 A device for the detection of Mycobactenum comprising a solid phase nucleic acid array comprising a plurality of Mycobacterium species specific oligonucleotides chemically linked to a solid polymeric support surface m a predetermined pattern 26 The device of claim 24, wherein said Mycobactenum species specific oligonucleotides comprises at least 15 contiguous nucleotides of one ot or more of SEQ ID NO 1 , SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11 , SEQ ID NO 12 SEQ ID NO 13, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 17, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 21 , SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31 SEQ ID NO 32, or SEQ ID NO 33 27 The device of claim 25, wherein the solid polymeric support surface is a polypropylene surface, and the plurality of Mycobactenum species specific oligonucleotides are arrayed in parallel lines on the support surface 28 A Mycobacterium-spccific ohgonucleotide consisting of a sequence of 15 consecutive base pairs of any one of SEQ ID NO 1 , SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5 , SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11 , SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 17, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 21 , SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31 , SEQ ID NO 32, or SEQ ID NO 33 29 The Mycobacterium specific ohgonucleotide of claim 28, wherein the ohgonucleotide is labeled 30 The Mycobactenum specific ohgonucleotide of claim 29, wherein the label is a fluorescent label, a radioactive label, or an enzymatic label 31 A Mycobactenum-specific ohgonucleotide consisting of a nucleic acid sequence as set forth as SEQ ID NO 1 , SEQ ID NO 2, SEQ ID NO 3 , SEQ ID NO 4, SEQ ID NO 5 , SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11 , SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 17, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 21 , SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29 SEQ ID NO 30, SEQ ID NO 31 , SEQ ID NO 32, or SEQ ID NO 33 32 The Mycobacterium specific ohgonucleotide of claim 31 , wherein the ohgonucleotide is labeled 33 The Mycobacterium specific ohgonucleotide of claim 32, wherein the label is a fluorescent label, a radioactive label, or an enzymatic label 34 A kit for detecting Mycobacterium specific nucleic acid, comprising a solid phase nucleic acid array comprising a plurality of Mycobacterium species specific oligonucleotides chemically linked to a solid polymeric support surface in a predetermined pattern, and a Mycobacterium genus selective primer or a Mycobacterium specific primer, in separate packaging 35 The kit of claim 34, further comprising an amplification enzyme, in separate packaging 36 The kit of claim 34, further comprising a buffer solution, m separate packaging

Inventors: CONVILLE PATRICIA S, FAHLE GARY A, FISCHER STEVEN H, RAMPAL JANG B, CONVILLE, PATRICIA, S., FAHLE, GARY, A., FISCHER, STEVEN, H., RAMPAL, JANG, B.
Applicants: BECKMAN COULTER INC, CONVILLE PATRICIA S, FAHLE GARY A, FISCHER STEVEN H, RAMPAL JANG B, US HEALTH, BECKMAN COULTER, INC., CONVILLE, PATRICIA, S., FAHLE, GARY, A., FISCHER, STEVEN, H., RAMPAL, JANG, B., THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH
Application year: 2001
Main classification: C12Q1
IPC codes: C12P19, C12Q1